# iShares Silver Trust: financial statements, quarterly

SLV · NYSE · CIK 1330568 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/slv.md) · [Financials](/companies/slv/financials.md) · [Filings](/companies/slv/filings.md) · [Insiders](/companies/slv/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/slv/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $bn | [(0.0)](/filings/0001437749-24-033818.md) | [(0.0) d](/filings/0001437749-26-006059.md) | [(0.0)](/filings/0001437749-25-033436.md) | [(0.0)](/filings/0001437749-25-033436.md) | [(0.0)](/filings/0001437749-25-033436.md) | [(0.0) d](/filings/0001437749-26-006059.md) | [(0.0)](/filings/0001437749-26-015539.md) | [(0.0)](/filings/0001437749-25-033436.md) | [(0.0)](/filings/0001437749-25-033436.md) | [(0.0) d](/filings/0001437749-26-006059.md) | [(0.1)](/filings/0001437749-26-015539.md) | not reported |
| Net income | $bn | [0.3](/filings/0001437749-24-033818.md) | [0.3 d](/filings/0001437749-26-006059.md) | [0.3](/filings/0001437749-25-033436.md) | [2.1](/filings/0001437749-25-033436.md) | [0.8](/filings/0001437749-25-033436.md) | [(1.0) d](/filings/0001437749-26-006059.md) | [2.3](/filings/0001437749-26-026005.md) | [0.9](/filings/0001437749-26-026005.md) | [5.0](/filings/0001437749-25-033436.md) | [13.1 d](/filings/0001437749-26-006059.md) | [0.5](/filings/0001437749-26-026005.md) | [(6.8)](/filings/0001437749-26-026005.md) |
| Basic EPS | $ per share | [0.62](/filings/0001437749-24-033818.md) | not reported | [0.63](/filings/0001437749-25-015169.md) | [4.45](/filings/0001437749-25-024885.md) | [1.59](/filings/0001437749-25-033436.md) | not reported | [4.66](/filings/0001437749-26-015539.md) | [1.79](/filings/0001437749-26-026005.md) | [9.29](/filings/0001437749-25-033436.md) | not reported | [0.88](/filings/0001437749-26-015539.md) | [(12.57)](/filings/0001437749-26-026005.md) |

- Revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Net income: us-gaap:NetIncomeLoss
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2020 (2020-03-31) | Q2 FY2020 (2020-06-30) | Q3 FY2020 (2020-09-30) | FY2020 (2020-12-31) | Q1 FY2021 (2021-03-31) | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) | FY2021 (2021-12-31) | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | FY2022 (2022-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $ | [0.0](/filings/0001437749-21-010721.md) | [0.0](/filings/0001437749-21-018892.md) | [0.0](/filings/0001437749-21-025051.md) | [0.0](/filings/0001437749-23-004332.md) | [0.0](/filings/0001437749-22-011362.md) | [0.0](/filings/0001437749-22-018859.md) | [0.0](/filings/0001437749-22-025350.md) | [0.0](/filings/0001437749-23-004332.md) | [0.0](/filings/0001437749-22-011362.md) | [0.0](/filings/0001437749-22-018859.md) | [0.0](/filings/0001437749-22-025350.md) | [0.0](/filings/0001437749-23-004332.md) |
| Total assets | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: not reported
- Total liabilities: not reported
- Shareholders' equity: not reported

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $ | [0.0 d](/filings/0001437749-24-033818.md) | [0.0 d](/filings/0001437749-26-006059.md) | [0.0](/filings/0001437749-25-015169.md) | [0.0 d](/filings/0001437749-25-024885.md) | [0.0 d](/filings/0001437749-25-033436.md) | [0.0 d](/filings/0001437749-26-006059.md) | [0.0](/filings/0001437749-26-015539.md) | [0.0 d](/filings/0001437749-26-026005.md) | [0.0 d](/filings/0001437749-25-033436.md) | [0.0 d](/filings/0001437749-26-006059.md) | [0.0](/filings/0001437749-26-015539.md) | [0.0 d](/filings/0001437749-26-026005.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

Shares outstanding: 538,200,000 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001437749-26-026005.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.